DOW
40
-2
CNX
40
-2
CAH
61
-5
CB
62
-5
AVGO
40
-5
AON
63
-2
COST
48
-3
ADSK
59
-2
DG
63
-2
CMA
59
-2
ECL
54
-5
EQIX
65
-2
ED
43
-2
BWA
48
-5
BXP
38
-3
BLK
52
-6
AAPL
53
-2
CTAS
39
-3
CAG
37
-3
APD
52
-3
DOW
40
-2
CNX
40
-2
CAH
61
-5
CB
62
-5
AVGO
40
-5
AON
63
-2
COST
48
-3
ADSK
59
-2
DG
63
-2
CMA
59
-2
ECL
54
-5
EQIX
65
-2
ED
43
-2
BWA
48
-5
BXP
38
-3
BLK
52
-6
AAPL
53
-2
CTAS
39
-3
CAG
37
-3
APD
52
-3
Financhill
Back

Inhibrx Biosciences, Inc. Vs. Rapt Therapeutics, Inc. Industry Stock Comparison

Sell
44

INBX
Inhibrx Biosciences, Inc.

Last Price:
$78.82
Seasonality Move:
-1.59%
Sell
38

RAPT
Rapt Therapeutics, Inc.

Last Price:
$33.91
Seasonality Move:
-28.15%
Sell
44
Inhibrx Biosciences, Inc. (INBX) is a Sell

Is Inhibrx Biosciences, Inc. a Buy, Sell or Hold?

  • The current Inhibrx Biosciences, Inc. [INBX] share price is $79.00. The Score for INBX is 44, which is 12% below its historic median score of 50, and infers higher risk than normal.
  • INBX is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
38
Rapt Therapeutics, Inc. (RAPT) is a Sell

Is Rapt Therapeutics, Inc. a Buy, Sell or Hold?

  • The current Rapt Therapeutics, Inc. [RAPT] share price is $33.87. The Score for RAPT is 38, which is 24% below its historic median score of 50, and infers higher risk than normal.
  • RAPT is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

INBX Stock Price Chart

What is Inhibrx Biosciences, Inc.'s stock price today?

  • The Inhibrx Biosciences, Inc. share price today is $79.00
    The current trend is moderately bearish and INBX is experiencing slight buying pressure.

RAPT Stock Price Chart

What is Rapt Therapeutics, Inc.'s stock price today?

  • The Rapt Therapeutics, Inc. share price today is $33.87
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and RAPT is experiencing slight buying pressure.

INBX Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 0.62 Buy
Relative Strength Index (14 RSI): 48.22 Sell
Chaikin Money Flow: 95108 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (79.04 - 87.1) Sell
Bollinger Bands (100): (27.43 - 79.25) Buy

RAPT Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 9.53 Buy
Relative Strength Index (14 RSI): 51.15 Buy
Chaikin Money Flow: 79100 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (32.58 - 35.84) Sell
Bollinger Bands (100): (16.83 - 33.91) Buy

INBX Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 81.07 Sell
20-day SMA: 83.16 Sell
50-day SMA: 77.38 Buy
200-day SMA: 34.4 Buy
8-day EMA: 80.28 Sell
20-day EMA: 81.12 Sell
50-day EMA: 73.58 Buy
200-day EMA: 43.75 Buy

RAPT Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 35 Sell
20-day SMA: 34.72 Sell
50-day SMA: 31.71 Buy
200-day SMA: 17.02 Buy
8-day EMA: 31.84 Buy
20-day EMA: 21.97 Buy
50-day EMA: 11.45 Buy
200-day EMA: 3.3 Buy

Inhibrx Biosciences, Inc. Earnings Growth & INBX Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.52 per share, a decrease next quarter of $0.00 per share, an increase this year of $4.25 per share, and an increase next year of $2.01 per share.

Rapt Therapeutics, Inc. Earnings Growth & RAPT Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.09 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.65 per share, and a decrease next year of $1.22 per share.

Inhibrx Biosciences, Inc. Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Rapt Therapeutics, Inc. Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):